School of Medicine, Yangzhou Polytechnic College, Yangzhou, China.
Department of Orthopaedics, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou, China.
Clin Exp Rheumatol. 2023 Nov;41(11):2239-2248. doi: 10.55563/clinexprheumatol/6xjdfn. Epub 2023 May 15.
Polycyclic aromatic hydrocarbons (PAHs) are environmental endocrine-disrupting compounds, which have been widely recognised as a risk factor for human health. However, the relationship between PAHs exposure and the risk of osteoarthritis has rarely been reported. This study aimed to investigate the association between individual and mixed exposure to PAHs and osteoarthritis.
In this cross-sectional study, participants aged ≥20 years with data on urinary PAHs and osteoarthritis were extracted from the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2016. Logistic regression analysis was utilised to assess the relationship between individual PAHs exposure and osteoarthritis. The quantile-based g computation (qgcomp) analysis and Bayesian kernel machine regression (BKMR) analysis were performed to assess the effect of mixed exposure to PAHs on osteoarthritis, respectively.
A total of 10,613 participants were enrolled, 980 (9.23%) of whom had osteoarthritis. Exposure to high levels of 1-hydroxynaphthalene (1-NAP) [odds ratio (OR)=1.06, 95% confidence interval (CI): 1.01-1.10], 3-hydroxyfluorene (3-FLU) (OR=1.09, 95%CI: 1.02-1.17), and 2-hydroxyfluorene (2-FLU) (OR=1.06, 95%CI: 1.01-1.13) were all associated with greater odds of osteoarthritis after adjusting for age, sex, body mass index, drinking alcohol, and hypertension. The qgcomp analysis showed that the joint weighted value of mixed PAHs exposure (OR=1.11, 95%CI: 1.02-1.22; p=0.017) was significantly related to higher odds of osteoarthritis. The BKMR analysis demonstrated that mixed exposure to PAHs was positively correlated with the risk of osteoarthritis.
Both individual and mixed exposure to PAHs were positively correlated with the risk of osteoarthritis.
多环芳烃(PAHs)是环境内分泌干扰物,已被广泛认为是人类健康的风险因素。然而,PAHs 暴露与骨关节炎风险之间的关系鲜有报道。本研究旨在探讨个体和混合 PAHs 暴露与骨关节炎之间的关系。
本横断面研究从 2001 年至 2016 年的国家健康和营养调查(NHANES)中提取了年龄≥20 岁、尿液 PAHs 数据和骨关节炎数据的参与者。采用 logistic 回归分析评估个体 PAHs 暴露与骨关节炎之间的关系。采用基于分位数的 g 计算(qgcomp)分析和贝叶斯核机器回归(BKMR)分析分别评估混合 PAHs 暴露对骨关节炎的影响。
共纳入 10613 名参与者,其中 980 名(9.23%)患有骨关节炎。高水平的 1-羟基萘(1-NAP)[比值比(OR)=1.06,95%置信区间(CI):1.01-1.10]、3-羟基芴(3-FLU)(OR=1.09,95%CI:1.02-1.17)和 2-羟基芴(2-FLU)(OR=1.06,95%CI:1.01-1.13)暴露均与调整年龄、性别、体重指数、饮酒和高血压后骨关节炎的发生几率增加相关。qgcomp 分析显示,混合 PAHs 暴露的联合加权值(OR=1.11,95%CI:1.02-1.22;p=0.017)与骨关节炎的发生几率升高显著相关。BKMR 分析表明,混合 PAHs 暴露与骨关节炎的风险呈正相关。
个体和混合 PAHs 暴露均与骨关节炎的风险呈正相关。